Apex drug regulator greenlights Serum’s covid and influenza combination vaccine trial; also approves Omicron vaccine
New Delhi: India’s apex drug regulator has approved the third phase of clinical trials for the country’s first combined covid-19 and influenza vaccine from Serum Institute of India (SII), according to two government officials and documents reviewed by. mint. In what is being viewed as a shot in the arm for India’s healthcare playbook, a…